Intratumoral lymphangiogenesis of esophageal squamous cell carcinoma and relationship with regulatory factors and prognosis

Pathology International

Volumn 58, Issue 10, 2008, Pages 611-619

  Inoue, Akemi ^a   Moriya, Hiromitsu ^b   Katada, Natsuya ^b   Tanabe, Satoshi ^c   Kobayashi, Nobuyuki ^d   Watanabe, Masahiko ^b   Okayasu, Isao ^b   Ohbu, Makoto ^c  

^a KITASATO UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KITASATO UNIVERSITY   (Japan)

^d Fuchinobe General Hospital   (Japan)

Author keywords

D2 40; Esophagus; Lymph node metastasis; Lymphangiogenesis; p53; Platelet derived growth factor A; Prognosis; Squamous cell carcinoma; Vascular endothelial growth factor A, C

Indexed keywords

MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR A; PROTEIN P53; VASCULOTROPIN A; VASCULOTROPIN C;

ADULT; ARTICLE; BLOOD VESSEL; CELL DENSITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPH NODES; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; PLATELET-DERIVED GROWTH FACTOR; RNA, MESSENGER; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 51749114246     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2008.02279.x     Document Type: Article

References (35)

1. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000 407 : 249 57.
2. Miyata Y, Kanda S, Ohba K et al. Lymphangiogenesis and angiogenesis in bladder cancer: Prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D. Clin Cancer Res 2006 12 : 800 6.
3. Gombos Z, Xu X, Chu CS, Zhang PJ, Acs G. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. Clin Cancer Res 2005 11 : 8364 71.
4. Miyahara M, Tanuma J, Sugihara K, Semba I. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Cancer 2007 110 : 1287 94.
5. Joukov V, Pajusola K, Kaipainen A et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996 15 : 290 98.
6. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 2005 201 : 1089 99.
7. Cao R, Bjorndahl MA, Religa P et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 2004 6 : 333 45.
8. Mukhopadhyay D, Tsiokas L, Sukhatme VP. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 1995 55 : 6161 5.
9. Kieser A, Weich HA, Brandner G, Marme D, Kolch W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 1994 9 : 963 9.
10. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma. N Engl J Med 1991 324 : 1 8.
11. Yamashita K, Yoshida T, Shinoda H, Okayasu I. Novel method for simultaneous analysis of p53 and K-ras mutations and p53 protein expression in single histologic sections. Arch Pathol Lab Med 2001 125 : 347 52.
12. Stocker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002 2 : 573 83.
13. Mueller AM, Franke FE, Muller KM. D2-40: A reliable marker in the diagnosis of pleural mesothelioma. Pathobiology 2006 73 : 50 54.
14. Bassarova AV, Nesland JM, Davidson B. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions. Am J Surg Pathol 2006 30 : 878 82.
15. Kahn HJ, Marks A. A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 2002 82 : 1255 7.
16. Dumoff KL, Chu C, Xu X, Pasha T, Zhang PJ, Acs G. Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix. Mod Pathol 2005 18 : 97 104.
17. Franchi A, Gallo O, Massi D, Baroni G, Santucci M. Tumor lymphangiogenesis in head and neck squamous cell carcinoma: A morphometric study with clinical correlations. Cancer 2004 101 : 973 8.
18. Dadras SS, Paul T, Bertoncini J et al. Tumor lymphangiogenesis a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 2003 162 : 1951 60.
19. Birner P, Schindi M, Obermair A, Breitenecker G, Kowalsk H, Oerhuber G. Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer. Int J Cancer 2001 95 : 29 33.
20. Schoppmann SF, Birner P, Stockl J et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 2002 161 : 947 56.
21. Moriya H, Kobayashi N, Okayasu I, Ohbu M. Prediction of lymph node metastasis of superficial esophageal carcinoma by analysis of tumor emboli within lymph vessels. Nihon Byorigakkaikaishi 2006 95 : 194 (in Japanese).
22. Beasley NJP, Prevo R, Banerji S et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 2002 62 : 1315 20.
23. Nathanson SD. Insights into the mechanisms of lymph node metastasis. Cancer 2003 98 : 413 23.
24. Padera TP, Kadambi A, Tomaso ED et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002 296 : 1883 86.
25. Maura S-M, Luukkaa M, Grenman R, Jackson D, Jalkanen S, Ristamaki R. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 2003 63 : 1920 26.
26. Kyzas PK, Geleff S, Batistatou A, Agnantis NJ, Stefanou D. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol 2005 206 : 170 77.
27. Chen W, Shen W, Chen M, Cai C, Liu X. Study on the relationship between lymphatic vessel density and distal intramural spread of rectal cancer. Eur Surg Res 2007 39 : 332 9.
28. Horiguchi A, Ito K, Sumitomo M, Kimura F, Asano T, Hayakawa M. Intratumoral lymphatics and lymphatic invasion are associated with tumor aggressiveness and poor prognosis in renal cell carcinoma. Urology 2008 71 : 928 32.
29. Sedivy R, Beck-Mannagetta J, Haverkampf C, Battistutti W, Honigschnabl S. Expression of vascular endothelial growth factor-C correlates with the lymphatic microvessel density and the nodal status in oral squamous cell cancer. J Oral Pathol Med 2003 32 : 455 60.
30. Olsson AK, Dimberg A, Kreuger J, Welsh LC. VEGF-receptor signaling: In control of vascular function. Nat Rev Mol Cell Biol 2006 7 : 359 71.
31. Cao R, Bjorndahl MA, Religa P et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 2006 2004 : 333 45.
32. Qin G, Kishore R, Dolan CM et al. Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF. Proc Natl Acad Sci USA 2006 103 : 11 015-20.
33. Kamat CD, Green DE, Warnke L, Thorpe JE, Ceriello A, Ihnat MA. Mutant p53 facilitates pro-angiogenic, hyperproliferative phenotype in response to chronic relative hypoxia. Cancer Lett 2007 249 : 209 19.
34. Karpanen T, Egeblad M, Karkkainen MJ et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 2001 61 : 1786 90.
35. Shimada H, Matsubara H, Shiratori T et al. Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma. Cancer Sci 2006 97 : 554 61.